Esophagogastric Junction Cancer
📧 Sign up to get email alerts when something new happens for Esophagogastric Junction Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer
A Semmelweis University study evaluating noninvasive prognostic parameters for esophageal cancer and the esophagogastric junction cancer; cu…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy [Phase 2, Phase 3]
A Phase 2/3 trial comparing ramucirumab plus FOLFIRI versus ramucirumab plus paclitaxel in patients with advanced or metastatic gastric/EGJ …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) [Phase 1]
Phase 1 study of ADP-A2M4CD8 as monotherapy or in combination with nivolumab or pembrolizumab in HLA-A2+ patients with MAGE-A4-positive tumo…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis [Phase 2]
Phase 2 trial evaluating combined systemic and intraperitoneal chemotherapy for synchronous gastric and gastroesophageal peritoneal carcinom…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) [Phase 2]
A Phase 2 clinical trial evaluating ONO-4578 in combination with Nivolumab and chemotherapy in chemotherapy-naïve patients with HER2-negativ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Neoadjuvant Treatment Modalities in Esophageal Cancer [Phase 3]
Phase 3 trial update evaluating neoadjuvant treatment modalities for esophageal cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer [Phase 3]
Phase 3 clinical trial evaluating chemoradiotherapy for esophageal cancer or esophagogastric junction cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors [Phase 1]
This clinical trial update describes a first-in-human Phase 1 study of an investigational therapy in adults with advanced solid tumors, incl…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: QL1706 Combined With SOX Used in Theperioperative Treatment [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating QL1706 in combination with the SOX chemotherapy regimen as perioperative treatment for gastric cancer …
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care
This clinical trial update describes the development of an AI-powered Clinical Decision Support System to assist cancer care and lists gastr…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) [Phase 3]
This clinical trial update describes a Phase 3 study evaluating ONO-4538 (nivolumab) in combination with ipilimumab and chemotherapy for che…
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer. [Phase 2]
Phase 2 study evaluating the myDIET software tool for nutritional management in patients with localized, resectable gastric or gastroesophag…
-
CLINICAL_TRIALS research · 2017-07-11Clinical Trial Update: Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma
This clinical trial update covers chemotherapy for potentially resectable locally advanced esophagogastric junction cancer, sponsored by Any…
-
CLINICAL_TRIALS research · 2015-08-10Clinical Trial Update: Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer [Phase 3]
This clinical trial update describes a Phase 3 neoadjuvant study comparing SLOT versus SOX regimens in locally advanced, resectable gastric …